FDA Reauthorization Act of 2017
Official title: “To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.”
What this law changes
Not startedPlain-language account: Not started
Transparency Score
The Transparency Score is the share of this law’s dollars that goes to what the law says it is for. We have not read this law for this section yet.
What this law changes in taxes
We have not read this law for this section yet.
Press releases by members of Congress
No saved press release names this law.
Read from 539 of 539 members' sites, releases since January 3, 2025, through October 8, 2026.
Press releases by organizations
No saved press release from these organizations names this law.
Read from 510 of 510 organizations' sites, releases since January 3, 2025, through October 8, 2026.
How it passed
The House passed it by voice vote on July 12, 2017. A voice vote records no individual votes.
The Senate passed it 94 to 1 on August 3, 2017, with 5 senators who did not vote.
It became law on August 18, 2017.
The question on the official record: Senate, “On Passage of the Bill H.R. 2430”.
| Chamber and party | Yes | No | Present | Did not vote |
|---|---|---|---|---|
| Senate Republicans | 47 | 0 | 0 | 5 |
| Senate Democrats | 46 | 0 | 0 | 0 |
| Senate independents | 1 | 1 | 0 | 0 |
How each member voted
Only Senate members have a recorded vote on this law.
100 members. Select a name to see that member's votes on laws that passed.
Where this comes from
A file marked "saved" is our own copy of the official file. The code beside it is its fingerprint, a short code that changes if the file's contents change. A file with no copy saved carries "Not published yet".